Invivyd, Inc. (IVVD)
(Real Time Quote from BATS)
$1.03 USD
-0.02 (-1.91%)
Updated Oct 18, 2024 02:36 PM ET
2-Buy of 5 2
B Value C Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 250)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.38 | 9.99 |
Current Quarter Estimate | -0.33 | 1.89 | 63.00 |
Year Ago Quarter Estimate | -0.36 | -4.97 | 52.25 |
Next Quarter Estimate | 0.17 | 3.30 | 66.00 |
Next Year Estimate | 0.02 | 22.26 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 66.85 | 17.20 | 15.67 |
Next Year | 103.33 | 10.10 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.68 |
Price/Book (MRQ) | 0.89 | 1.95 |
Price/Cash Flow (MRFY) | NA | 14.78 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -101.26% |
Return on Equity (TTM) | -109.72% | -66.38% |
Debt to Equity (MRQ) | NA | 40.92 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.